. Erratum: Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial. J Clin Oncol 2024 Nov 19:JCO2402458. doi: 10.1200/JCO-24-02458.
PMID: 39561313